x

Posted 01 December, 2021

INTEGRA LIFESCIENCES HOLDINGS CORP appointed Jan D. De Witte as new CEO

Nasdaq:IART appointed new Chief Executive Officer Jan D. De Witte in a 8-K filed on 01 December, 2021.


  As previously disclosed, on October 28, 2021, Integra LifeSciences Holdings Corporation (the "Company") announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of INTEGRA LIFESCIENCES HOLDINGS CORP
Health Care/Life Sciences • Medical Equipment/Supplies
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Market Cap
$2.87B
View Company Details
INTEGRA LIFESCIENCES HOLDINGS CORP by TradingView
Relevant filing section
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS


As previously disclosed, on October 28, 2021, Integra LifeSciences Holdings Corporation (the "Company") announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer. In connection with his appointment as President and Chief Executive Officer of the Company, the Board of Directors of the Company (the "Board") also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment.


On December 1, 2021, Mr. De Witte commenced employment with the Company as its President and Chief Executive Officer and was appointed as a director of the Board, with his term as a director expiring at the Company's 2022 annual meeting of stockholders.


In connection with the commencement of Mr. De Witte's employment as President and Chief Executive Officer of the Company, Peter J. Arduini's previously-announced resignation from his position as President and Chief Executive Officer and a director of the Company became effective as of December 1, 2021.